Summary box nº 5 • 2-[18F]FDG PET/CT can be useful for determining the extent of metastatic disease (outside the brain) and improving treatment planning (III-100%/C-100%) • 2-[18F]FDG PET/CT can be done instead of, and not in addition to separate conventional imaging modalities (combination of bone scan, chest X-ray or CT-chest, and ultrasound of the liver or CT-abdomen) (II-100%/B-100%)

The parenthesis contains the level of evidence—percentage of agreement/grade of recommendation—percentage of agreement for each statement.